Unknown

Dataset Information

Different associations between organ-specific immune-related adverse event and survival in non-small cell lung cancer patients treated with programmed death-1 inhibitors-based combination therapy.


ABSTRACT:

Background

The profile of immune-related adverse events (irAEs) due to programmed death-1 (PD-1) inhibitors-based combination therapy in advanced non-small cell lung cancer (NSCLC) and its relationship with survival have not been fully described.

Objective

Designed to capture the spectrum of irAEs and explore the association between irAEs and clinical outcomes in patients with NSCLC.

Design

This retrospective single-center study included patients with advanced NSCLC treated with PD-1 inhibitors (mainly in combination with chemotherapy) at Jiangsu Cancer Hospital.

Methods

The relationship between irAEs and survival was explored using landmark analysis and time-dependent Cox regression. The subgroup analyses focused on investigating the effects of organ-specific

SUBMITTER: Chen Y 

PROVIDER: S-EPMC10644755 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature